Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,707 | 95 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $327.82 | 23 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $211.67 | 11 | $0 (2024) |
| ABBVIE INC. | $156.39 | 8 | $0 (2024) |
| ITI, Inc. | $153.66 | 8 | $0 (2023) |
| Lilly USA, LLC | $117.60 | 7 | $0 (2024) |
| Lundbeck LLC | $114.38 | 6 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $86.50 | 5 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $80.11 | 4 | $0 (2024) |
| Axonics, Inc. | $79.28 | 1 | $0 (2023) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $66.74 | 4 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $555.09 | 30 | Novo Nordisk Inc ($101.26) |
| 2023 | $658.06 | 37 | Novo Nordisk Inc ($146.64) |
| 2022 | $493.81 | 28 | Novo Nordisk Inc ($79.92) |
All Payment Transactions
95 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/19/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $19.59 | General |
| Category: PSYCHIATRY | ||||||
| 11/13/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $20.11 | General |
| Category: PSYCHIATRY | ||||||
| 10/22/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $16.70 | General |
| Category: PSYCHIATRY | ||||||
| 10/18/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $21.89 | General |
| Category: Diabetes | ||||||
| 10/16/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $15.71 | General |
| Category: PSYCHIATRY | ||||||
| 10/09/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $22.04 | General |
| Category: PSYCHIATRY | ||||||
| 09/17/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $17.86 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/11/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $18.71 | General |
| Category: PSYCHIATRY | ||||||
| 09/05/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $21.38 | General |
| Category: Diabetes | ||||||
| 08/14/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $19.74 | General |
| Category: PSYCHIATRY | ||||||
| 08/13/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $13.15 | General |
| Category: Diabetes | ||||||
| 07/30/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $20.63 | General |
| Category: Diabetes | ||||||
| 07/08/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $18.93 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 06/27/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.80 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/10/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $19.49 | General |
| Category: Diabetes | ||||||
| 05/23/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $21.55 | General |
| Category: Cardio-renal | ||||||
| 05/23/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $16.13 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 05/21/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $15.94 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 05/09/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $15.05 | General |
| Category: PSYCHIATRY | ||||||
| 05/07/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $16.08 | General |
| Category: PSYCHIATRY | ||||||
| 04/22/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $26.79 | General |
| Category: NEUROSCIENCE | ||||||
| 04/11/2024 | Paratek Pharmaceuticals, Inc. | NUZYRA (Drug) | Food and Beverage | In-kind items and services | $17.18 | General |
| Category: ANTIBIOTIC | ||||||
| 04/08/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $16.73 | General |
| Category: Diabetes | ||||||
| 03/27/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $17.98 | General |
| Category: PSYCHIATRY | ||||||
| 03/22/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $15.85 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 1 | 25 | 30 | $5,490 | $1,298 |
| 2022 | 4 | 138 | 146 | $32,116 | $6,803 |
| 2021 | 3 | 146 | 154 | $35,895 | $12,712 |
All Medicare Procedures & Services
8 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 25 | 30 | $5,490 | $1,298 | 23.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 90 | 93 | $24,210 | $3,872 | 16.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 16 | 16 | $3,240 | $1,694 | 52.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 21 | 25 | $4,423 | $1,211 | 27.4% |
| 81003 | Automated urinalysis test | Office | 2022 | 11 | 12 | $243.00 | $24.75 | 10.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 85 | 91 | $23,660 | $7,066 | 29.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 44 | 44 | $8,910 | $4,592 | 51.5% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 17 | 19 | $3,325 | $1,054 | 31.7% |
About Heather Wright, NP
Heather Wright, NP is a Nurse Practitioner healthcare provider based in Warner Robins, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/19/2020. The National Provider Identifier (NPI) number assigned to this provider is 1538768866.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Heather Wright, NP has received a total of $1,707 in payments from pharmaceutical and medical device companies, with $555.09 received in 2024. These payments were reported across 95 transactions from 23 companies. The most common payment nature is "Food and Beverage" ($1,707).
As a Medicare-enrolled provider, Wright has provided services to 309 Medicare beneficiaries, totaling 330 services with total Medicare billing of $20,812. Data is available for 3 years (2021–2023), covering 8 distinct procedure/service records.
Practice Information
- Specialty Nurse Practitioner
- Location Warner Robins, GA
- Active Since 10/19/2020
- Last Updated 12/30/2025
- Taxonomy Code 363L00000X
- Entity Type Individual
- NPI Number 1538768866
Products in Payments
- REXULTI (Drug) $306.38
- Ozempic (Drug) $214.54
- CAPLYTA (Drug) $207.75
- VRAYLAR (Drug) $140.92
- Rybelsus (Drug) $113.28
- FARXIGA (Drug) $86.50
- Kerendia (Drug) $80.11
- Axonics (Device) $79.28
- MOUNJARO (Drug) $78.74
- JARDIANCE (Drug) $50.59
- SPIRIVA RESPIMAT (Drug) $38.04
- Otezla (Drug) $35.84
- QUVIVIQ (Drug) $34.89
- LEQVIO (Drug) $34.12
- Dexcom G6 Transmitter (Medical Supply) $22.15
- ABILIFY MAINTENA (Drug) $19.67
- NEXLETOL (Drug) $18.93
- ACCRUFER (Drug) $17.47
- NUZYRA (Drug) $17.18
- INJECTAFER (Drug) $17.00
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nurse Practitioner Doctors in Warner Robins
Mrs. Tamika Chester, Np, NP
Nurse Practitioner — Payments: $11,896
Mrs. Kelly Murray, Np, NP
Nurse Practitioner — Payments: $11,247
Shakema Cooper, Np-Bc, NP-BC
Nurse Practitioner — Payments: $5,549
Sonia Evans
Nurse Practitioner — Payments: $3,759
Mrs. Tausha Rhoades, Agacnp-Bc, AGACNP-BC
Nurse Practitioner — Payments: $2,864
Selvi Fults, Np-C, NP-C
Nurse Practitioner — Payments: $2,325